Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.

PLoS One · 2017 · PMC5386327 · PMID 28394917

Europe PMC DOI

hedged sentence

0.3150

closest p · 6.3× alpha

0.3150

boldest claim

The sentences

did not reach statistical significanceP = 0.315not close (p > 0.1)

On p-tau, four of five patients showed lower p-tau levels after the treatment than baseline, although the difference did not reach statistical significance (P = 0.315).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.